Affiliation:
1. DEPARTMENT OF RHEUMATOLOGY AND CONNECTIVE TISSUE DISEASES, MEDICAL UNIVERSITY OF LUBLIN, LUBLIN, POLAND
Abstract
Systemic sclerosis (SSc) is a multi-organ connective tissue disease that leads to the dysfunction and the impaired morphology of blood vessels due to non-specific inflammation
and progressive fibrosis. Due to the diversity of SSc and even though the factors predisposing to the severe course of SSc are known, it is not always possible to predict the
disease progression and to determine the prognosis. Ideally, the group of patients with faster progression of organ lesions and a worse course of the disease should be identified
and the early intensive treatment should be instituted.
The aim of the article, is an attempt to identify the factors that worsen the prognosis in the course of SSc.
The analysis of numerous studies demonstrated that patients with short-lasting SSc, with the presence of anti-RNA polymerase III antibodies, with a generalized type of SSc with
quickly progressing skin lesions and males should be most strictly monitored. Moreover, vascular complications, tendon ruptures and fast capillaries loss observed in nailfold
capillaroscopy are the factors deteriorating the prognosis in SSc.
In conclusion, despite the known, the factors that worsen the prognosis, it is difficult to predict the course of systemic sclerosis. Due to its incompletely elucidated etiopathology
as well as the diverse and unpredictable nature of the disease, reliable markers to determine the prognosis in SSc have not been found.
Reference17 articles.
1. 1. Bellando-Randone S, Matucci-Cerinic M. Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions. Curr Rheumatol Rep. 2017;19:65.
2. 2. Hao Y, Hudson M, Baron M, et al. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. Arthritis Rheumatol. 2017;69:1067- 1077.
3. 3. Herrick AL, Peytrignet S, Lunt M, et al. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis. 2018;77:563-570.
4. 4. Kowal-Bielecka O, Domysławska I, Sierakowski S. Ocena zmian skórnych u chorych na twardzinę układową: uwagi praktyczne i znaczenie kliniczne. Reumatologia 2005; 43:310-312.
5. 5. Strickland G, Pauling J, Cavill C, et al. Mortality in systemic sclerosis-a single centre study from the UK. Clin Rheumatol. 2013;32:1533-1539
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献